Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

The passage of President Trump's signature tax cut bill shows how the health care industry's influence is waning.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.

When female athletes collapse on the playing field, they are less likely to be resuscitated than men: How gender differences ...

From my colleague Andrew Joseph: Novartis said today that Swiss regulators have approved its malaria medicine Coartem for newborns and young infants, extending a long-standing treatment to the ...

NIH freeze on grants, indirect-cost research cuts lead young scientists to look at opportunities abroad. "A fire sale on American academics right now." ...

Join STAT on July 9 to explore how Deep Human Biology Learning is accelerating drug discovery. Register now for this groundbreaking virtual event.

States race to secure billions in Medicaid funding before Congress caps future deals, as new federal rules and GOP tax plans threaten provider payments.

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July. Corrigan-Curay, who took over as acting director of the ...